Experts On... Translating biomarker discoveries into real-world assays | Dr. Phil Worboys

Dr. Phil Worboys, Head of Translational Science at Sapient, explains how rLC-MS can be leveraged for high throughput, nontargeted discovery screenings, and how biomarkers identified through this method are then validated both biologically and technically to translate the discovery into a robust, targeted assay.